BioNano Genomics (BNGO) Q2 2023 Earnings Report
MX:BNGO Q2 2023 EPS Results
- Actual EPS
- -MXN 1,382.41
- Consensus EPS
- -MXN 1,162.23
- Beat/Miss
- Missed by -MXN 220.18
- One Year Ago EPS
- -MXN 1,226.33
MX:BNGO Q2 2023 Revenue Results
- Actual Revenue
- MXN 160.95M
- Expected Revenue
- MXN 154.09M
- Beat/Miss
- Beat by +MXN 6.86M
- YoY Revenue Growth
- +29.87%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- After Close
- Conference Call
- Wednesday, August 9, 2023
MX:BNGO Upcoming Earnings
BioNano Genomics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
MX:BNGO Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNGO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -8.36- | -37.9 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -12.45-12.26 | -37.16 | 67.00% (+24.90) | |
| May 13, 2026 | 2026 (Q1) | -16.35-14.12 | -21.37 | 33.91% (+7.25) | |
| Mar 23, 2026 | 2025 (Q4) | -45.99-28.80 | -225.48 | 87.23% (+196.68) | |
| Nov 13, 2025 | 2025 (Q3) | -38.56-37.90 | -579.72 | 93.46% (+541.82) | |
| Aug 14, 2025 | 2025 (Q2) | -49.37-37.16 | -267.56 | 86.11% (+230.40) | |
| May 14, 2025 | 2025 (Q1) | ―- | -668.91 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -56.17-21.37 | -668.91 | 96.81% (+647.54) | |
| Nov 13, 2024 | 2024 (Q3) | -220.20-579.72 | -3589.81 | 83.85% (+3010.09) | |
| Aug 07, 2024 | 2024 (Q2) | -463.00-267.56 | -1382.41 | 80.65% (+1114.85) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
